Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,5 USD | -0,57% | +6,71% | -20,09% |
Vakgebied
Aantal werknemers: 30
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Prescription Drug Products
100,0
%
| 21 | 100,0 % | 32 | 100,0 % | +48,90% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 21 | 100,0 % | 32 | 100,0 % | +48,90% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sean Brynjelsen
CEO | Chief Executive Officer | 52 | 01-06-17 |
James Gruber
DFI | Director of Finance/CFO | 52 | 11-04-22 |
Lisa M. Wilson
IRC | Investor Relations Contact | 59 | - |
Corporate Officer/Principal | - | - | |
Sales & Marketing | - | 01-08-18 | |
Ingrid Hoos
LAW | General Counsel | - | - |
David Krempa
PRN | Corporate Officer/Principal | 35 | 01-09-17 |
Kevin Guthrie
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 78 | 01-06-17 | |
Paul Maier
BRD | Director/Board Member | 76 | 14-09-17 |
Norbert Riedel
CHM | Chairman | 66 | 07-09-17 |
Sean Brynjelsen
CEO | Chief Executive Officer | 52 | 01-06-17 |
Jenn Adams
BRD | Director/Board Member | - | 01-03-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 25 688 062 | 22 356 695 ( 87,03 %) | 0 | 87,03 % |
Bedrijfsgegevens
Eton Pharmaceuticals, Inc.
21925 West Field Parkway Suite 235
60010-7278, Deer Park
+
http://www.etonpharma.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-20,09% | 89,91 mln. | |
+3,37% | 69,25 mld. | |
+12,55% | 9 mld. | |
-12,75% | 4,96 mld. | |
+42,38% | 4,47 mld. | |
+5,23% | 3,9 mld. | |
+19,58% | 2,45 mld. | |
-19,05% | 2,41 mld. | |
-28,72% | 2,23 mld. | |
+11,13% | 2,02 mld. |
- Beurs
- Aandelen
- Koers ETON
- Onderneming Eton Pharmaceuticals, Inc.